Contraception: progress brings hope for new methods for men

For decades, pundits have predicted new contraceptives for men within the next 5 to 10 years. Are we really getting any closer? Judging from work presented today at the second "Future of Male Contraception" conference, the answer may finally be yes.

But will men actually use a new method if researchers make one? Elaine Lissner, director of the nonprofit Male Contraception Information Project, says demand is the least of the problems. "You'll never have all men interested, but attitudes have really changed-- studies consistenly show a majority of men would consider it. You have to remember, between condoms and vasectomy, men in the U.S. are already taking care of a third of contraception. Just imagine if they had another non-permanent option."

Kirsten Thompson, director of the International Male Contraception Coalition, concurs. "Some men are quite desperate for better control over their fertility. They're looking for something they can really count on."

Among the developments announced at the conference:

-- Researchers from the University of Pittsburgh and BIOQUAL Inc. showed they could provide contraception in monkeys with no hormones and no shots needed. (Monkeys are used for studies because of their similarity to humans.) The monkeys had no moving sperm after they took a compound called CDB-4022, and their fertility bounced back completely by 16 weeks. The researchers hope this will be a new nonhormonal contraceptive that can be taken as a pill; in survey results presented at the conference by the International Male Contraception Coalition, 61% of men listed a nonhormonal drug as their first choice. Safety studies will be the next step.

-- A testosterone-like pill ("selective androgen receptor modulator") already in human testing as an osteoporosis and muscle-wasting treatment may have a side benefit: it could work as a hormonal contraceptive that could be taken as a pill. Until now, most "male Pill" research has used a combination of shots, implants, or gels. The SARM's industry support (by GTx, Inc.) gives it a good chance at commercialization.

-- Another androgen that can be taken orally, Dimethandrolone Undecanoate (DMAU), was effective at reducing sperm numbers in rabbits if taken at a low, but not high, dose. Rabbits regained their fertility when they stopped the drug.

-- Makers of the Intra Vas Device are expected to announce effectiveness data showing "substantial equivalence to traditional vasectomy methods” in a study of 90 men. The Intra Vas Device blocks sperm in the vas deferens, the tube sperm swim through that is cut in vasectomy. The set of plugs can be removed if a man changes his mind, and animal studies have shown that fertility returns if it is removed after short-term use. The next step will be to find funding for long-term studies of effectiveness and fertility return.

-- Developers of a home sperm test ("SpermCheck") reported excellent results in men. The test perfectly matched more expensive laboratory tests in detecting whether men's sperm count is above or below 200,000-300,000 per millileter, an extremely low number (normal counts are above 20 million per millileter). When this test hits the market, it will help men who are using "do-it-yourself" methods such as simple wet heat and suspensories. It will also allow men who get vasectomies to know when their sperm are cleared out, without going to the doctor. About 1 in 6 American couples uses vasectomy as a contraceptive method, with more than 500,000 men opting for the procedure each year.

Researchers from around the world are also announcing new targets for contraception, and incremental progress on hormonal approaches ("the male Pill"). Many other teams will present late-breaking news during the poster session, 7-9 pm the 27th.

Source: Male Contraception Information Project

Related stories:

New concepts in contraception
Latest research into dual-purpose contraceptives and non-hormonal contraception will be presented tomorrow at a major scientific conference in Melbourne.
American culture in conflict with traditional values of Hispanic male immigrants
Traditional family values may be strongest among immigrant men in one of the fastest growing populations of American society. A recent study by researchers at the University of Missouri-Columbia is one of the first to intently interview Hispanic immigrant men in focus groups about their opinions and concerns toward family planning in the United States.
Male contraception: One door opens, another closes
We have often heard that a new male contraceptive is "five to ten years" away. But are we getting any closer? The answer may finally be "yes." This week marked the announcement of one hot new lead and one dead end.
Male Rivalry Increases when Females at Most Fertile, Say Researchers
Men become more jealous of dominant males when their female partner is near ovulation, researchers at the University of Liverpool have found.
Education needed to decrease teens' misconception about emergency contraception
Targeted health education may help urban, minority adolescent women better understand how the emergency contraception pill works and eliminate some misconceptions about side effects, confidentiality and accessibility, according to a study by The Children's Hospital of Philadelphia.
Population policy needed for the UK in order to combat climate change
The biggest contribution UK couples can make to combating climate change would be to have only two children or at least have one less than they first intended, argues an editorial published on BMJ.com today.
Learning to talk to teens about sex -- while at work
Sex is one of the most difficult topics a parent can bring up with an adolescent, but a new study finds that parents who are taught specific communication skills can more readily tackle these conversations and sustain them over time.
New choices bring wider range of women to family planning
A study appearing in the March 2008 issue of the journal Contraception reports that the Standard Days Method®, a natural family planning method developed by researchers from Georgetown University Medical Center’s Institute for Reproductive Health, brings new women to family planning. More than half the women who selected the Standard Days Method had never previously used family planning and on average, contraceptive use increased by 8 percent in communities where the method was introduced.

News discussion:

Medicine & Health news